Skip to content
DraconiticResearch
Search Sources API
203,234 studies31 sourcesUpdated 9 min ago
Peer-reviewedCC BY 4.0Cureus

Prognostic Value of Blood Ammonia, Lactate, and Brain Natriuretic Peptide in Pediatric Patients With Sepsis: A Prospective, Observational Study

  1. 1Pediatric Cardiology, Indira Gandhi Institute of Medical Sciences, Patna, IND
  2. 2Pediatrics, Indira Gandhi Institute of Medical Sciences, Patna, IND

Abstract

Background: Early identification of children with sepsis who are at risk of adverse outcomes is essential for timely intervention and optimal management.

Objectives: To evaluate the prognostic significance of serum lactate, blood ammonia, and brain natriuretic peptide (BNP) levels in children with sepsis admitted to the Pediatric Intensive Care Unit (PICU).

Methods: This prospective cohort observational study was conducted in the PICU of the Department of Paediatrics at the Indira Gandhi Institute of Medical Sciences, Patna, over 18 months. Seventy-nine children aged 1 month to 14 years with sepsis were enrolled. Serial measurements of serum lactate and blood ammonia were obtained on day 0, day 3, and day 7, while BNP levels were measured on day 0 and day 3. Clinical outcomes were recorded, and prognostic accuracy was assessed with receiver operating characteristic curve analysis.

Results: Of the 73 patients included in the final analysis, 22 (30.1%) died. Non-survivors demonstrated higher levels of lactate, ammonia, and BNP than survivors. The area under the receiver operating characteristic curve (AUROC) for admission lactate was 0.741, with a cutoff of >3.29 mmol/L, a sensitivity of 54.55%, and a specificity of 92.16%. Ammonia demonstrated an AUROC of 0.713, while BNP had the highest AUROC (0.933) for predicting in-hospital mortality.

Conclusion: Lactate, ammonia, and BNP demonstrated prognostic associations with in-hospital mortality in children with sepsis. BNP showed the highest AUROC among the evaluated biomarkers. These findings should be interpreted cautiously, given the observational design and limited sample size, and should be validated in larger, multicenter cohorts.

Related

  1. Transfusion practices, thresholds, and complications in pediatric oncology patients: a single-center prospective longitudinal observational study
    Büşra Tunalı Özcan, Sonay İncesoy Özdemir, Handan Dinçaslan +6
    Frontiers in pediatricsPeer-reviewedCC BYFull textGeneral medicineEurope PMC
  2. Risk factors and predictive value of lung ultrasound aeration score for postoperative pulmonary complications in pediatric patients undergoing abdominal tumor resection: a prospective observational study
    Jie Guo, Li-Quan Huang, Zhi-Xiang Yu +6
    BMC AnesthesiologyPeer-reviewedCC BY 4.0Full textGeneral medicinePMC
  3. Prognostic value of modified thrombelastometry for thromboembolic risk stratification in neurosurgical patients: protocol for a prospective, multicenter, observational study (TENS).
    Hi-Jae Heiroth, Philipp Groene, Simon Schäfer +14
    Diagnostic and prognostic researchPeer-reviewedCC BYFull textGeneral medicineEurope PMCPMC
  4. Complications and predictors of catheter failure in pediatric long peripheral and midline catheters: a prospective observational study
    Jonathan Adalia Rodríguez, Violeta Marín Padillo
    Journal of Infection PreventionPeer-reviewedLicence not statedFull textGeneral medicinePMC
  5. Natriuretic Peptide Receptor-C (NPR3) in Pulmonary Hypertension Associated with Chronic Lung Disease: A PRISMA-ScR Scoping Review of Diagnostic, Prognostic, Mechanistic, and Therapeutic Evidence
    Emmanuel Eroume A Egom, Adamou Mfopa, Njimona Ibrahim +4
    Journal of clinical medicinePeer-reviewedCC BYFull textGeneral medicineEurope PMC
BibTeX
@article{kumar2026prognostic,
  title = {{Prognostic Value of Blood Ammonia, Lactate, and Brain Natriuretic Peptide in Pediatric Patients With Sepsis: A Prospective, Observational Study}},
  author = {Dharmpal Kumar and Amit Kumar and Rakesh Kumar and Jayant Prakash},
  journal = {Cureus},
  year = {2026},
  month = oct,
  doi = {10.7759/cureus.117450},
  url = {https://doi.org/10.7759/cureus.117450},
  note = {CC BY 4.0},
}
RIS
TY  - JOUR
TI  - Prognostic Value of Blood Ammonia, Lactate, and Brain Natriuretic Peptide in Pediatric Patients With Sepsis: A Prospective, Observational Study
AU  - Dharmpal Kumar
AU  - Amit Kumar
AU  - Rakesh Kumar
AU  - Jayant Prakash
PY  - 2026
DA  - 2026/10/04
JO  - Cureus
DO  - 10.7759/cureus.117450
UR  - https://doi.org/10.7759/cureus.117450
AB  - Background: Early identification of children with sepsis who are at risk of adverse outcomes is essential for timely intervention and optimal management.  Objectives: To evaluate the prognostic significance of serum lactate, blood ammonia, and brain natriuretic peptide (BNP) levels in children with sepsis admitted to the Pediatric Intensive Care Unit (PICU).  Methods: This prospective cohort observational study was conducted in the PICU of the Department of Paediatrics at the Indira Gandhi Institute of Medical Sciences, Patna, over 18 months. Seventy-nine children aged 1 month to 14 years with sepsis were enrolled. Serial measurements of serum lactate and blood ammonia were obtained on day 0, day 3, and day 7, while BNP levels were measured on day 0 and day 3. Clinical outcomes were recorded, and prognostic accuracy was assessed with receiver operating characteristic curve analysis.  Results: Of the 73 patients included in the final analysis, 22 (30.1%) died. Non-survivors demonstrated higher levels of lactate, ammonia, and BNP than survivors. The area under the receiver operating characteristic curve (AUROC) for admission lactate was 0.741, with a cutoff of >3.29 mmol/L, a sensitivity of 54.55%, and a specificity of 92.16%. Ammonia demonstrated an AUROC of 0.713, while BNP had the highest AUROC (0.933) for predicting in-hospital mortality.  Conclusion: Lactate, ammonia, and BNP demonstrated prognostic associations with in-hospital mortality in children with sepsis. BNP showed the highest AUROC among the evaluated biomarkers. These findings should be interpreted cautiously, given the observational design and limited sample size, and should be validated in larger, multicenter cohorts.
SN  - 2168-8184
ER  -